157 related articles for article (PubMed ID: 24841453)
1. An evaluation of the reclassification of ophthalmic chloramphenicol for the management of acute bacterial conjunctivitis in community pharmacies in Western Australia.
Alkhatib L; Parsons R; Czarniak P; Sunderland VB
Int J Pharm Pract; 2015 Apr; 23(2):111-20. PubMed ID: 24841453
[TBL] [Abstract][Full Text] [Related]
2. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
[TBL] [Abstract][Full Text] [Related]
3. An investigation of prescription and over-the-counter supply of ophthalmic chloramphenicol in Wales in the 5 years following reclassification.
Du HC; John DN; Walker R
Int J Pharm Pract; 2014 Feb; 22(1):20-7. PubMed ID: 23590558
[TBL] [Abstract][Full Text] [Related]
4. Management of acute infective conjunctivitis.
Drug and Therapeutics Bulletin
Drug Ther Bull; 2011 Jul; 49(7):78-81. PubMed ID: 21733975
[TBL] [Abstract][Full Text] [Related]
5. Prescribing and sale of ophthalmic chloramphenicol following reclassification to over-the-counter availability.
Walker R; Hinchliffe A
Int J Pharm Pract; 2010 Oct; 18(5):269-74. PubMed ID: 20840682
[TBL] [Abstract][Full Text] [Related]
6. Community pharmacists' perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China.
Song M; Ung CO; Lee VW; Hu Y; Zhao J; Li P; Hu H
BMC Complement Altern Med; 2017 Jan; 17(1):9. PubMed ID: 28056935
[TBL] [Abstract][Full Text] [Related]
7. Managing migraine with over-the-counter provision of triptans: the perspectives and readiness of Western Australian community pharmacists.
Booth S; Parsons R; Sunderland B; Sim TF
PeerJ; 2019; 7():e8134. PubMed ID: 31871835
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists' perceived integration into practice of over-the-counter simvastatin five years post reclassification.
Paudyal V; Hansford D; Cunningham S; Stewart D
Int J Clin Pharm; 2012 Oct; 34(5):733-8. PubMed ID: 22740232
[TBL] [Abstract][Full Text] [Related]
9. Australian pharmacies prevent potential adverse reactions in patients taking warfarin requesting over-the-counter analgesia.
MacFarlane BV; Bergin JK; Reeves P; Matthews A
Int J Pharm Pract; 2015 Jun; 23(3):167-72. PubMed ID: 25359613
[TBL] [Abstract][Full Text] [Related]
10. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
11. Assessing pharmacists' readiness to prescribe oral antibiotics for limited infections using a case-vignette technique.
Ung E; Czarniak P; Sunderland B; Parsons R; Hoti K
Int J Clin Pharm; 2017 Feb; 39(1):61-69. PubMed ID: 27848173
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacists' perceptions about pharmaceutical care of OTC western medicine: a survey in Harbin of China.
Song M; Ung CO; Hu H; Wang Y
Int J Clin Pharm; 2015 Dec; 37(6):1014-20. PubMed ID: 26286338
[TBL] [Abstract][Full Text] [Related]
13. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services.
Kritikos VS; Reddel HK; Bosnic-Anticevich SZ
Int J Pharm Pract; 2010 Aug; 18(4):209-16. PubMed ID: 20636672
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional survey of enhanced and extended professional services in community pharmacies: A pharmacy perspective.
Sim TF; Wright B; Hattingh L; Parsons R; Sunderland B; Czarniak P
Res Social Adm Pharm; 2020 Apr; 16(4):511-521. PubMed ID: 31300355
[TBL] [Abstract][Full Text] [Related]
16. Non-prescription medicines: current issues in Australian community pharmacy.
Tan AC; Emmerton L
Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
[TBL] [Abstract][Full Text] [Related]
17. Management of over-the-counter insomnia complaints in Australian community pharmacies: a standardized patient study.
Kashyap KC; Nissen LM; Smith SS; Kyle G
Int J Pharm Pract; 2014 Apr; 22(2):125-34. PubMed ID: 23947610
[TBL] [Abstract][Full Text] [Related]
18. Seeing red: over-the-counter chloramphenicol.
Robaei D; Naunton M; Watson S
Clin Exp Ophthalmol; 2015 Mar; 43(2):99-100. PubMed ID: 25833086
[No Abstract] [Full Text] [Related]
19. Relative impact of clinical evidence and over-the-counter prescribing on topical antibiotic use for acute infective conjunctivitis.
Davis H; Mant D; Scott C; Lasserson D; Rose PW
Br J Gen Pract; 2009 Dec; 59(569):897-900. PubMed ID: 20875257
[TBL] [Abstract][Full Text] [Related]
20. Community pharmacists' views, attitudes and early experiences of over-the-counter simvastatin.
Hansford D; Cunningham S; John D; McCaig D; Stewart D
Pharm World Sci; 2007 Aug; 29(4):380-5. PubMed ID: 17357811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
